Transcription factor and drug-metabolizing enzyme gene expression in lymphocytes from healthy human subjects

Drug Metabolism and Disposition

Volumn 36, Issue 1, 2008, Pages 182-189

  Siest, Gérard ^a   Jeannesson, Elise ^a   Marteau, Jean Brice ^a   Samara, Anastasia ^a   Marie, Bérangère ^a   Pfister, Michèle ^a   Visvikis Siest, Sophie ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; AROMATIC HYDROCARBON RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2A6; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2; CYTOCHROME P450 4A11; CYTOCHROME P450 4F2; DRUG METABOLIZING ENZYME; GLUCOCORTICOID RECEPTOR; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; HYPOXIA INDUCIBLE FACTOR 1BETA; LEUKOTRIENE; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MESSENGER RNA; MYOCYTE ENHANCER FACTOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PREGNANE X RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; FEMALE; GENE EXPRESSION; HUMAN; LYMPHOCYTE; MALE; METABOLISM; MICROARRAY ANALYSIS; NORMAL HUMAN; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA ISOLATION;

CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION; GLUTATHIONE TRANSFERASE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, STEROID;

EID: 37549069338     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.017228     Document Type: Article

References (49)

1. Asghar A, Gorski JC, Haehner-Daniels B, and Hall SD (2002) Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. Drug Metab Dispos 30:20-26.
2. Baron JM, Zwadlo-Klarwasser G, Jugert F, Hamann W, Rubben A, Mukhtar H, and Merk HF (1998) Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 56:1105-1110.
3. Boucher P, Seree E, Vidon C, de Souza AC, Villard PH, Chambon R, Barra Y, and Vallon JJ (2000) Dietary lipids affect human ethanol-inducible CYP2E1 gene expression in vivo in mononuclear cells. Life Sci 67:1307-1316.
4. Carcillo JA, Adedoyin A, Burckart GJ, Frye RF, Venkataramanan R, Knoll C, Thummel K, Roskos L, Wilson JW, Sereika S, et al. (2003) Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation. Clin Pharmacol Ther 73:456-467.
5. Chen Y, Ferguson SS, Negishi M, and Goldstein JA (2003) Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol Pharmacol 64:316-324.
6. Daly AK (2006) Significance of the minor cytochrome P450 3A isoforms. Clin Pharmacokinet 45:13-31.
7. Dassi C, Signorini S, Gerthoux P, Cazzaniga M, and Brambilla P (1998) Cytochrome P450 1B1 mRNA measured in blood mononuclear cells by quantitative reverse transcription-PCR. Clin Chem 44:2416-2421.
8. Drocourt L, Ourlin JC, Pascussi JM, Maurel P, and Vilarem MJ (2002) Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277:25125-25132.
9. Dvorak Z, Modriansky M, Pichard-Garcia L, Balaguer P, Vilarem MJ, Ulrichova J, Maurel P, and Pascussi JM (2003) Colchicine down-regulates cytochrome P450 2B6, 2C8, 2C9, and 3A4 in human hepatocytes by affecting their glucocorticoid receptor-mediated regulation. Mol Pharmacol 64:160-169.
10. Elbekai RH and El-Kadi AO (2006) Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther 112:564-587.
11. Ferguson SS, Chen Y, LeCluyse EL, Negishi M, and Goldstein JA (2005) Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha. Mol Pharmacol 68:747-757.
12. Finnström N, Ask B, Dahl ML, Gadd M, and Rane A (2002) Intra-individual variation and sex differences in gene expression of cytochromes P450 in circulating leukocytes. Pharmacogenomics J 2:111-116.
13. Finnström N, Thorn M, Loof L, and Rane A (2001) Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease. Eur J Clin Pharmacol 57:403-409.
14. Furukawa M, Nishimura M, Ogino D, Chiba R, Ikai I, Ueda N, Naito S, Kuribayashi S, Moustafa MA, Uchida T, et al. (2004) Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci 95:520-529.
15. Gashaw I, Kirchheiner J, Goldammer M, Bauer S, Seidemann J, Zoller K, Mrozikiewicz PM, Roots I, and Brockmoller J (2003) Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics. Clin Pharmacol Ther 74:448-457.
16. Gueguen Y, Mouzat K, Ferrari L, Tissandie E, Lobaccaro JM, Batt AM, Paquet F, Voisin P, Aigueperse J, Gourmelon P, et al. (2006) [Cytochromes P450: xenobiotic metabolism, regulation and clinical importance]. Ann Biol Clin (Paris) 64:535-548.
17. Haas CE, Brazeau D, Cloen D, Booker BM, Frerichs V, Zaranek C, Frye RF, and Kufel T (2005) Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction. Eur J Clin Pharmacol 61:583-593.
18. Handschin C and Meyer UA (2005) Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 433:387-396.
19. Hannon-Fletcher MP, O'Kane MJ, Moles KW, Barnett YA, and Barnett CR (2001) Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects. Food Chem Toxicol 39:125-132.
20. Jones DC, Manning BM, and Daynes RA (2002) A role for the peroxisome proliferator-activated receptor alpha in T-cell physiology and ageing immunobiology. Proc Nutr Soc 61:363-369.
21. Kirchheiner J, Tsahuridu M, Jabrane W, Roots I, and Brockmöller J (2004) The CYP2C9 polymorphism: from enzyme kinetics to clinical dose recommendations. Personalized Med 1:63-84.
22. Koskela S, Hakkola J, Hukkanen J, Pelkonen O, Sorri M, Saranen A, Anttila S, Fernandez-Salguero P, Gonzalez F, and Raunio H (1999) Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 57:1407-1413.
23. Krovat BC, Tracy JH, and Omiecinski CJ (2000) Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicol Sci 55:352-360.
24. Lampe JW, Stepaniants SB, Mao M, Radich JP, Dai H, Linsley PS, Friend SH, and Potter JD (2004) Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 13:445-453.
25. Landi MT, Bergen AW, Baccarelli A, Patterson DG Jr, Grassman J, Ter-Minassian M, Mocarelli P, Caporaso N, Masten SA, Pesatori AC, et al. (2005) CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from Seveso, Italy. Toxicology 207:191-202.
26. Landi MT, Bertazzi PA, Baccarelli A, Consonni D, Masten S, Lucier G, Mocarelli P, Needham L, Caporaso N, and Grassman J (2003) TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident. Carcinogenesis 24:673-680.
27. Liangpunsakul S, Kolwankar D, Pinto A, Gorski JC, Hall SD, and Chalasani N (2005) Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics. Hepatology 41:1144-1150.
28. Lin P, Hu SW, and Chang TH (2003) Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol Sci 71:20-26.
29. Marteau JB, Mohr S, Pfister M, and Visvikis-Siest S (2005) Collection and storage of human blood cells for mRNA expression profiling: a 15-month stability study. Clin Chem 51:1250-1252.
30. Miao W, Hu L, Kandouz M, Hamilton D, and Batist G (2004) A cell-based system to identify and characterize the molecular mechanism of drug-metabolizing enzyme (DME) modulators. Biochem Pharmacol 67:1897-1905.
31. Miura R, Nakamura K, Miura D, Miura A, Hisamatsu K, Kajiya M, Hashimoto K, Nagase S, Morita H, Fukushima Kusano K, et al. (2006) Aldosterone synthesis and cytokine production in human peripheral blood mononuclear cells. J Pharmacol Sci 102:288-295.
32. Nakamoto T, Hase I, Imaoka S, Hiroi T, Oda Y, Asada A, and Funae Y (2000) Quantitative RT-PCR for CYP3A4 mRNA in human peripheral lymphocytes: induction of CYP3A4 in lymphocytes and in liver by rifampicin. Pharmacogenetics 10:571-575.
33. Nguyen LT, Ramanathan M, Weinstock-Guttman B, Dole K, Miller C, Planter M, Patrick K, Brownscheidle C, and Jacobs LD (2000) Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays. Drug Metab Dispos 28:987-993.
34. Pascussi JM, Gerbal-Chaloin S, Drocourt L, Maurel P, and Vilarem MJ (2003) The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619:243-253.
35. Pitarque M, Rodriguez-Antona C, Oscarson M, and Ingelman-Sundberg M (2005) Transcriptional regulation of the human CYP2A6 gene. J Pharmacol Exp Ther 313:814-822.
36. Raucy JL, Schultz ED, Wester MR, Arora S, Johnston DE, Omdahl JL, and Carpenter SP (1997) Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab Dispos 25:1429-1435.
37. Smart J and Daly AK (2000) Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 10:11-24.
38. Spencer DL, Masten SA, Lanier KM, Yang X, Grassman JA, Miller CR, Sutter TR, Lucier GW, and Walker NJ (1999) Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes. Cancer Epidemiol Biomarkers Prev 8:139-146.
39. Stärkel P, Sempoux C, Van Den Berge V, Stevens M, De Saeger C, Desager JP, and Horsmans Y (1999) CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin. Life Sci 64:643-653.
40. Sueyoshi T and Negishi M (2001) Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41:123-143.
41. Szabova L, Macejova D, Dvorcakova M, Mostbock S, Blazickova S, Zorad S, Walrand S, Cardinault N, Vasson MP, Rock E, et al. (2003) Expression of nuclear retinoic acid receptor in peripheral blood mononuclear cells (PBMC) of healthy subjects. Life Sci 72:831-836.
42. Takeda Y, Furukawa K, Inaba S, Miyamori I, and Mabuchi H (1999) Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. J Clin Endocrinol Metab 84:1633-1637.
43. Toide K, Yamazaki H, Nagashima R, Itoh K, Iwano S, Takahashi Y, Watanabe S, and Kamataki T (2003) Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins. Cancer Epidemiol Biomarkers Prev 12:219-222.
44. Trifilieff A, Bench A, Hanley M, Bayley D, Campbell E, and Whittaker P (2003) PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect. Br J Pharmacol 139:163-171.
45. Tuominen R, Warholm M, Moller L, and Rannug A (2003) Constitutive CYP1B1 mRNA expression in human blood mononuclear cells in relation to gender, genotype, and environmental factors. Environ Res 93:138-148.
46. Visvikis-Siest S, Marteau JB, Samara A, Berrahmoune H, Marie B, and Pfister M (2007) Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems. Clin Chem Lab Med 45:1154-1168.
47. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, and Brown PO (2003) Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100:1896-1901.
48. Wibaut-Berlaimont V, Randi AM, Mandryko V, Lunnon MW, Haskard DO, and Naoumova RP (2005) Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis. J Thromb Haemost 3:677-685.
49. Yamamoto J, Ihara K, Nakayama H, Hikino S, Satoh K, Kubo N, Iida T, Fujii Y, and Hara T (2004) Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. Life Sci 74:1039-1049.